Archives-2017

Patent for prof. Krzysztof Zabłocki

On September 21st the Patent Office of the Republic of Poland granted a patent (number P. 414785) for an invention entitled: “Application of 3-(dodecylsulfanyl)-butanoic acid as a medicine for prevention of insulin resistance and pharmaceutical composition containing 3-(dodecylsulfanyl)-butanoic 3-(dodecylsulfanyl)-butanoic acidacid  as an active ingredient”. Patent application was submitted to the Patent Office jointly by the Nencki Institute of Experimental Biology and the University of ...